Results 21 to 30 of about 2,238 (188)

Approach to Pregnancy Affected by Kell Alloimmunization

open access: yesCase Reports in Hematology
Hemolytic disease of the fetus and newborn (HDFN) is the development of anemia, hyperbilirubinemia, and finally hydrops fetalis in the fetus when antibodies to antigens on the surface of erythrocytes are transferred from the placenta to the fetus.
Serdar Aykut   +7 more
doaj   +2 more sources

Clinical Characteristics of Early-Onset Severe Hemolytic Disease of the Fetus and Newborn and Treatment Efficacy of Serial Intrauterine Transfusions: A 10-Year Single-Center Experience in China [PDF]

open access: yesMaternal-Fetal Medicine
. Objective:. To summarize the clinical characteristics of early-onset severe hemolytic disease of the fetus and newborn (HDFN) in a Chinese cohort and identify factors influencing intrauterine transfusion (IUT) frequency and pregnancy outcomes. Methods:
Quanrui Liu   +7 more
doaj   +2 more sources

Homo Sapiens (Hsa)-microRNA (miR)-6727-5p Contributes to the Impact of High-Density Lipoproteins on Fibroblast Wound Healing In Vitro [PDF]

open access: yesMembranes, 2022
Chronic, non-healing wounds are a significant cause of global morbidity and mortality, and strategies to improve delayed wound closure represent an unmet clinical need.
Khaled Mahmoud Bastaki   +4 more
doaj   +2 more sources

Kell alloimmunization in pregnancy: Lessons to be learnt

open access: yesGlobal Journal of Transfusion Medicine, 2017
With the introduction of anti-D prophylaxis, the incidence of RhD alloimmunization in pregnancy has been significantly reduced. RhD remains the most common cause of hemolytic disease of fetus and newborn (HDFN).
Rajeswari Subramaniyan
doaj   +2 more sources

Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review

open access: yesBMC Pregnancy and Childbirth
Background Hemolytic disease of the fetus and newborn (HDFN) is a condition due to maternal blood group antibodies targeting antigens in fetal red blood cells, with significant prenatal/perinatal morbidity and mortality.
Mário Dias Corrêa Júnior   +5 more
doaj   +2 more sources

Hemolytic disease of the fetus and newborn caused by irregular antibody: A mortality case report and case series during the past 15 years in NCKUH

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2022
Objective: Hemolytic disease of the fetus and newborn (HDFN) caused by irregular antibodies is a rare, but possibly life-threatening condition. We report a case of severe intrauterine hemolysis caused by anti-E alloimmunization, and review 16 cases in ...
Ming-Ta Chuang, Chiung-Hsin Chang
doaj   +2 more sources

Adverse perinatal outcomes indicative of RhD-mediated hemolytic disease of the fetus and newborn in Eastern Ethiopia: evidence of maternal health inequity in a multicenter cohort studyAJOG Global Reports at a Glance [PDF]

open access: yesAJOG Global Reports
BACKGROUND: Although hemolytic disease of the fetus and newborn (HDFN) has become rare in high-income countries, it remains a significant cause of perinatal death in low-and middle-income countries.
Assefa Desalew, MSc   +9 more
doaj   +2 more sources

Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies [PDF]

open access: yesJMIR Research Protocols
BackgroundHemolytic disease of the fetus and newborn (HDFN) is a rare but serious condition caused by maternal-fetal red blood cell antigen incompatibility.
Nana A Mensah   +12 more
doaj   +2 more sources

Characterization of the clinical course of early‐onset severe hemolytic disease of the fetus and newborn [PDF]

open access: yesPregnancy
Introduction Severe fetal anemia developing at ≤24 weeks gestational age (GA) in pregnancies complicated by early‐onset severe hemolytic disease of the fetus and newborn (EOS‐HDFN) is managed by intrauterine erythrocyte transfusions (IUTs).
Dick Oepkes   +20 more
doaj   +2 more sources

Global, Regional and National Burden of Hemolytic Disease and Other Neonatal Jaundice, 1980/90‐2021, and Projections to 2050: A Global Burden of Disease Study 2021 [PDF]

open access: yesHealth Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background and Aims Hemolytic disease of the fetus and newborn and other forms of neonatal jaundice remain important causes of morbidity and mortality among children under five worldwide. Despite improvements in prevention and treatment such as Rh screening, phototherapy, and exchange transfusion, the burden remains uneven across regions. This
Chalie Mulugeta   +7 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy